Skip to content

Federal Contractor Profile

Crestone, INC.

$60M obligated·5 awards·2 agencies·3 NAICS

Federal Contracts

Showing award actions 1–26 of 26 funded award actions, most recent first.

Contracts with positive obligations
5
Funded award actions shown
26
Obligations shown
$60M
Awarding agencies
2

This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.

Award data as of August 20, 2026. Source: USAspending federal award records.

DateAgencyPIIDNAICSDescriptionAmount
Jun 16, 2026Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93019C00056541714TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018$1.4M
Apr 23, 2026Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93020C00020541715TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.$1.6M
Jan 7, 2026Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93020C00020541715TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.$2.0M
Jun 25, 2025Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93019C00056541714TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018$3.3M
Dec 3, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93019C00056541714TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018$573K
Nov 26, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93020C00020541715TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.$1.6M
Aug 7, 2024Department of Veterans AffairsNETWORK CONTRACT OFFICE 19 (36C259)36C25924P1167541714SYNTHESIS AND TESTING LABORATORY SERVICES FOR RESEARCH$99K
Aug 1, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93019C00056541714TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018$4.6M
Jun 7, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93020C00020541715TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.$971K
Aug 31, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93020C00020541715TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.$2.7M
Aug 17, 2023Department of Veterans AffairsNETWORK CONTRACT OFFICE 19 (36C259)36C25923P1093541714SYNTHESIS AND TESTING OF NOVEL ANTIBIOTIC CHEMICAL COMPOUNDS FOR ROCKY MOUNTAIN REGIONAL VA MEDICAL CENTER RESEARCH DEPARTMENT$102K
Jul 20, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93019C00056541714TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018$3.5M
Sep 29, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93020C00020541715TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.$141K
Sep 20, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93019C00056541714TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018$4.5M
Sep 20, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93020C00020541715TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.$5.8M
Dec 10, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93020C00020541715TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.$3.7M
Dec 4, 2020Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93019C00056541714TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018$851K
Aug 12, 2020Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93019C00056541714TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018$9.8M
Jun 29, 2020Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93020C00020541715TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.$3.7M
Apr 13, 2020Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93019C00056541714TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018$1.3M
Sep 5, 2019Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93019C00056541714TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018$3.4M
Jun 29, 2019Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN272201500012C541711IGF::OT::IGF - OPTIMIZATION OF POLC POLYMERASE INHIBITORS FOR TREATMENT OF HIGH PRIORITY GRAM-POSITIVE PATHOGENS.$82K
Sep 18, 2018Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN272201500012C541711IGF::OT::IGF - OPTIMIZATION OF POLC POLYMERASE INHIBITORS FOR TREATMENT OF HIGH PRIORITY GRAM-POSITIVE PATHOGENS.$477K
Oct 23, 2017Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN272201500012C541711IGF::OT::IGF - OPTIMIZATION OF POLC POLYMERASE INHIBITORS FOR TREATMENT OF HIGH PRIORITY GRAM-POSITIVE PATHOGENS.$1.8M
Feb 7, 2017Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN272201500012C541711IGF::OT::IGF - OPTIMIZATION OF POLC POLYMERASE INHIBITORS FOR TREATMENT OF HIGH PRIORITY GRAM-POSITIVE PATHOGENS.$298K
Aug 24, 2016Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAIDHHSN272201500012C541711IGF::OT::IGF - OPTIMIZATION OF POLC POLYMERASE INHIBITORS FOR TREATMENT OF HIGH PRIORITY GRAM-POSITIVE PATHOGENS.$1.5M

Get Alerted Before Crestone, INC.'s Next Recompete

Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.

Start for free